Suppr超能文献

血脂异常和高尿酸血症:中国芜湖居民的横断面研究。

Dyslipidemia and hyperuricemia: a cross-sectional study of residents in Wuhu, China.

机构信息

School of Public Health, Wannan Medical College, 22 West Wenchang Road, 241002, Wuhu, Anhui Province, China.

School of Clinical Medicine, Wannan Medical College, 22 West Wenchang Road, 241002, Wuhu, Anhui Province, China.

出版信息

BMC Endocr Disord. 2024 Jan 2;24(1):2. doi: 10.1186/s12902-023-01528-7.

Abstract

BACKGROUND

While dyslipidemia has been recognized as a potential risk factor for hyperuricemia, there is currently a dearth of large-scale data specifically focused on studying the relationship between these two conditions. To address this gap, the present study analyzed a dataset of 298,891 physical examination records to investigate in greater detail the clinical classification and compositional relationship between hyperuricemia and dyslipidemia.

METHODS

For this investigation, a cross-sectional research design was utilized to analyze physical examination data that was gathered from Yijishan Hospital in Wuhu, China between 2011 and 2016. Logistic regression was employed to examine the association between hyperuricemia and dyslipidemia. Furthermore, the association between hyperuricemia and dyslipidemia was evaluated based on the clinical classifications of dyslipidemia and its components.

RESULTS

A total of 298,891 participants from China (124,886 [41.8%] females) were included in the study, with an age range of 18 to 90 years (mean [SD]: 47.76 [13.54] years). In multivariate analysis, the odds of hyperuricemia was 1.878 times higher in patients with dyslipidemia compared to those without dyslipidemia (95% confidence interval [CI]: 1.835-1.922). In the clinical classification of dyslipidemia, individuals with hypertriglyceridemia and mixed hyperlipidemia had 1.753 times (95% CI: 1.706-1.802) and 1.925 times (95% CI: 1.870-1.982) higher odds of hyperuricemia, respectively, compared to those without dyslipidemia. Among the components of dyslipidemia, the odds ratios for hyperuricemia in individuals in the fourth quartile compared to those in the first quartile were 3.744 (95% CI: 3.636-3.918) for triglycerides, 1.518 (95% CI: 1.471-1.565) for total cholesterol, and 1.775 (95% CI: 1.718 - 1.833) for non-high-density lipoprotein cholesterol.

CONCLUSIONS

Dyslipidemia has been independently linked with hyperuricemia. Moreover, the elevation of triglycerides or total cholesterol levels, including conditions such as hypertriglyceridemia and mixed hyperlipidemia, have been observed to have a positive association with the development of hyperuricemia.

摘要

背景

虽然血脂异常已被认为是高尿酸血症的一个潜在危险因素,但目前缺乏专门针对这两种情况之间关系的大规模数据。为了解决这一差距,本研究分析了 298891 份体检记录数据集,以更详细地研究高尿酸血症和血脂异常的临床分类和组成关系。

方法

本研究采用横断面研究设计,对 2011 年至 2016 年在中国芜湖弋矶山医院采集的体检数据进行分析。采用 logistic 回归分析高尿酸血症与血脂异常之间的关系。此外,根据血脂异常的临床分类及其成分评估高尿酸血症与血脂异常之间的关系。

结果

本研究共纳入 298891 名来自中国的参与者(女性 124886 名[41.8%]),年龄为 18 至 90 岁(平均[SD]:47.76[13.54]岁)。多变量分析显示,与无血脂异常者相比,血脂异常者发生高尿酸血症的几率高 1.878 倍(95%置信区间[CI]:1.835-1.922)。在血脂异常的临床分类中,与无血脂异常者相比,高甘油三酯血症和混合性高脂血症患者发生高尿酸血症的几率分别高 1.753 倍(95%CI:1.706-1.802)和 1.925 倍(95%CI:1.870-1.982)。在血脂异常的成分中,与第 1 四分位相比,第 4 四分位的个体发生高尿酸血症的比值比(OR)分别为 3.744(95%CI:3.636-3.918)、1.518(95%CI:1.471-1.565)和 1.775(95%CI:1.718-1.833)。

结论

血脂异常与高尿酸血症独立相关。此外,甘油三酯或总胆固醇水平升高,包括高甘油三酯血症和混合性高脂血症等情况,与高尿酸血症的发生呈正相关。

相似文献

1
Dyslipidemia and hyperuricemia: a cross-sectional study of residents in Wuhu, China.
BMC Endocr Disord. 2024 Jan 2;24(1):2. doi: 10.1186/s12902-023-01528-7.
5
The relationship between dyslipidemia and inflammation among adults in east coast China: A cross-sectional study.
Front Immunol. 2022 Aug 11;13:937201. doi: 10.3389/fimmu.2022.937201. eCollection 2022.
8
Associations of urinary zinc exposure with blood lipid profiles and dyslipidemia: Mediating effect of serum uric acid.
Sci Total Environ. 2024 Feb 20;912:168951. doi: 10.1016/j.scitotenv.2023.168951. Epub 2023 Dec 1.

引用本文的文献

2
Lipoprotein(a) and its linear association with all-cause and cardiovascular mortality in patients with acute coronary syndrome.
Front Endocrinol (Lausanne). 2025 May 27;16:1580298. doi: 10.3389/fendo.2025.1580298. eCollection 2025.
3
Chitosan-Based Nanoparticles Targeted Delivery System: In Treatment Approach for Dyslipidemia.
Int J Nanomedicine. 2025 May 24;20:6611-6636. doi: 10.2147/IJN.S517492. eCollection 2025.
5
Association between life's essential 8 and hyperuricemia among adults in the United States: insights from NHANES 2005-2018.
Front Med (Lausanne). 2024 Nov 6;11:1455164. doi: 10.3389/fmed.2024.1455164. eCollection 2024.
6
Serum Uric Acid and Iron Status: Exploring a Complex Interaction in Metabolic Syndrome Patients of Eastern India.
Cureus. 2024 Oct 4;16(10):e70803. doi: 10.7759/cureus.70803. eCollection 2024 Oct.
7
A study on the correlation between hyperuricemia and TG/HDL-c ratio in the Naxi ethnic group at high-altitude regions of Yunnan.
Front Med (Lausanne). 2024 Aug 12;11:1416021. doi: 10.3389/fmed.2024.1416021. eCollection 2024.
9
Associations between estradiol and hyperuricemia and the mediating effects of TC, TG, and TyG: NHANES 2013-2016.
Front Endocrinol (Lausanne). 2024 Aug 7;15:1422470. doi: 10.3389/fendo.2024.1422470. eCollection 2024.

本文引用的文献

1
Non-HDL-cholesterol in dyslipidemia: Review of the state-of-the-art literature and outlook.
Atherosclerosis. 2023 Oct;383:117312. doi: 10.1016/j.atherosclerosis.2023.117312. Epub 2023 Sep 30.
2
Prevalence and Risk Factors of Hyperuricemia and Gout: A Cross-sectional Survey from 31 Provinces in Mainland China.
J Transl Int Med. 2022 Jul 7;10(2):134-145. doi: 10.2478/jtim-2022-0031. eCollection 2022 Jun.
4
Noninvasive and Individual-Centered Monitoring of Uric Acid for Precaution of Hyperuricemia via Optical Supramolecular Sensing.
Adv Sci (Weinh). 2022 Jun;9(18):e2104463. doi: 10.1002/advs.202104463. Epub 2022 Apr 28.
8
Global epidemiology of dyslipidaemias.
Nat Rev Cardiol. 2021 Oct;18(10):689-700. doi: 10.1038/s41569-021-00541-4. Epub 2021 Apr 8.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验